Literature DB >> 7671968

Defective galactosylation in galactosemia: is low cell UDPgalactose an explanation?

S Segal1.   

Abstract

There is circumstantial evidence that defective galactosylation of complex glycoconjugates exists in tissues from galactosemic patients. Whether this is an etiologic factor in the long-term complications of the disorder is not known. Also not evident is the basis for the impaired galactosylation. The hypothesis that abnormally low cellular uridine diphosphate galactose (UDPgal) content is responsible has not been established. There is a tendency for galactosemic red cell UDPgal to be in the low normal range with a high uridine diphosphate glucose to UDP-gal ratio. This may reflect an inability of red cell UDPgal-4'-epimerase to maintain a normal ratio and consequently higher levels of UDPgal. In the more complex white blood cells and cultured fibroblasts, the UDPgal content and the uridine diphosphate glucose to UDPgal ratio of galactosemics are normal. Therefore, defective galactosylation observed in galactosemic fibroblasts must result from a defect in the transfer of galactose from UDPgal to these moieties.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671968     DOI: 10.1007/bf02143806

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  Defective galactosylation of proteins in cultured skin fibroblasts from galactosaemic patients.

Authors:  J A Dobbie; J B Holton; J R Clamp
Journal:  Ann Clin Biochem       Date:  1990-05       Impact factor: 2.057

2.  Deficit of uridine diphosphate galactose in galactosaemia.

Authors:  W G Ng; Y K Xu; F R Kaufman; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  The neuropathology of galactosemia. A histopathological and biochemical study.

Authors:  C Haberland; M Perou; E G Brunngraber; H Hof
Journal:  J Neuropathol Exp Neurol       Date:  1971-07       Impact factor: 3.685

4.  A human milk galactosyltransferase is specific for secreted, but not plasma, IgA.

Authors:  E J McGuire; R Kerlin; J J Cebra; S Roth
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

5.  Uridine diphosphate hexoses in leukocytes and fibroblasts of classic galactosemics and patients with other metabolic diseases.

Authors:  J B Gibson; R A Reynolds; M J Palmieri; B States; G T Berry; S Segal
Journal:  Pediatr Res       Date:  1994-11       Impact factor: 3.756

6.  Uridine diphosphoglucose content of human erythrocytes: assessment by conversion to uridine diphosphoglucuronate.

Authors:  J B Gibson; R A Reynolds; S Rogers; M J Palmieri; S Segal
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

Review 7.  Galactosemia: the uridine diphosphate galactose deficiency-uridine treatment controversy.

Authors:  J B Holton; F de la Cruz; H L Levy
Journal:  J Pediatr       Date:  1993-12       Impact factor: 4.406

8.  31P NMR spectra of intact red blood cells: quantitation of UDPGlucose and UDPGalactose.

Authors:  S L Wehrli; M J Palmieri; R A Reynolds; S Segal
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

9.  The investigation of UDPGlucose and UDPGalactose concentration in red blood cells of patients with classical galactosaemia.

Authors:  N J Keevill; J B Holton; J T Allen
Journal:  Clin Chim Acta       Date:  1993-11-30       Impact factor: 3.786

10.  The concentration of red blood cell UDPglucose and UDPgalactose determined by high-performance liquid chromatography.

Authors:  M J Palmieri; G T Berry; D A Player; S Rogers; S Segal
Journal:  Anal Biochem       Date:  1991-05-01       Impact factor: 3.365

View more
  6 in total

1.  Komrower Lecture. Galactosaemia today: the enigma and the challenge.

Authors:  S Segal
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

2.  Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.

Authors:  Michael Boyce; Isaac S Carrico; Anjali S Ganguli; Seok-Ho Yu; Matthew J Hangauer; Sarah C Hubbard; Jennifer J Kohler; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

3.  Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4'-epimerase (GALE).

Authors:  Jane Odhiambo Mumma; Juliet S Chhay; Kerry L Ross; Jana S Eaton; Karen A Newell-Litwa; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2007-11-05       Impact factor: 4.797

Review 4.  Galactosemia unsolved.

Authors:  S Segal
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

5.  Ovotoxic effects of galactose involve attenuation of follicle-stimulating hormone bioactivity and up-regulation of granulosa cell p53 expression.

Authors:  Sayani Banerjee; Pratip Chakraborty; Piyali Saha; Soma Aditya Bandyopadhyay; Sutapa Banerjee; Syed N Kabir
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

6.  Metabolomics shows the Australian dingo has a unique plasma profile.

Authors:  Sonu Yadav; Russell Pickford; Robert A Zammit; J William O Ballard
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.